---
title: "Disc Medicine amends Hercules loan agreement, draws down $30 million tranche"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/291329349.md"
description: "Disc Medicine amended its loan agreement with Hercules Capital, drawing down $30 million from Tranche 1-B. The company split the existing $50 million Tranche 1-C into two $25 million tranches (1-D and another) available through March and April 2027 respectively. Additionally, draw periods for Tranche 2 and 3 were extended to December 2027 and June 2028, while the minimum cash covenant testing start date was revised to July 2028."
datetime: "2026-06-30T20:17:11.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/291329349.md)
  - [en](https://longbridge.com/en/news/291329349.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/291329349.md)
generator: "portal-rs"
---

# Disc Medicine amends Hercules loan agreement, draws down $30 million tranche

-   Disc Medicine entered a first amendment to its 2024 loan agreement with Hercules Capital to extend availability for future advances. \* Drawdown of USD 30 million under the Tranche 1-B Advance. \* Split the existing USD 50 million Tranche 1-C Advance into USD 25 million available through March 31, 2027, USD 25 million Tranche 1-D through April 30, 2027. \* Extended draw periods for the Tranche 2 Advance to Dec. 15, 2027, Tranche 3 Advance to June 30, 2028. \* Revised minimum cash covenant to start testing on July 1, 2028. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Disc Medicine Inc. i published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001193125-26-290542), on June 30, 2026, and is solely responsible for the information contained therein. © Copyright 2026 - Public Technologies (PUBT) Original Document: here

### Related Stocks

- [IRON.US](https://longbridge.com/en/quote/IRON.US.md)
- [HTGC.US](https://longbridge.com/en/quote/HTGC.US.md)
- [HCXY.US](https://longbridge.com/en/quote/HCXY.US.md)

## Related News & Research

- [Disc Medicine COO Jonathan Yen-Wen Yu disposes of 9,096 common shares worth $755,192.83](https://longbridge.com/en/news/297100562.md)
- [Disc Medicine management joins fireside chats at upcoming investor conferences](https://longbridge.com/en/news/297782168.md)
- [Disc Medicine to present initial Phase 2 RESTORE-PV data for DISC-3405 in polycythemia vera at SOHO 2026](https://longbridge.com/en/news/297565790.md)
- [Disc Medicine Announces Multiple Presentations Across Portfolio at the Society of Hematologic Oncology (SOHO) 2026 Annual Meeting | IRON Stock News](https://longbridge.com/en/news/297566501.md)
- [Disc Medicine, Inc. $IRON Shares Bought by Algert Global LLC](https://longbridge.com/en/news/297392693.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**